FDA loses in court in campaign against Ivermectin COVID-19 treatment thumbnail

FDA loses in court in campaign against Ivermectin COVID-19 treatment

By O’Keefe Media Group

Starting 2021, the FDA mounted a campaign against ivermectin – an inexpensive, Nobel Prize-winning medication that showed promising signs in the early treatment of COVID-19.

While the death toll from this campaign is difficult to calculate, the impact was far-reaching. The campaign was used as fuel to terminate employment of doctors who understood the science behind ivermectin, as well as justification for pharmacies to cease filling ivermectin prescriptions when people needed the medication most.

Courageous doctors fought back.

In 2022, doctors filed a federal lawsuit against the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) over the agencies’ unlawful attempts to block the use of ivermectin for treatment of COVID-19.

“We’re suing the FDA for lying to the public about ivermectin,” said Dr. Bowden, a plaintiff in the case.

The complaint directly cites US laws, including the provision that the FDA “may not interfere with the authority of a health care provider to prescribe or administer any legally marked device to a patient for any condition or disease within a legitimate health care practitioner-patient relationship.”

On Thursday last week, the court ruled against the FDA and mandated the removal of all previous social media posts that specifically addressed the use of ivermectin for the treatment or prevention of COVID-19. The posts have started to come down, including a popular one titled: “Should I take ivermectin to prevent or treat COVID-19? No.”

RELATED VIDEO: ‘Sick: Unmasking Big Medicine’ by The Daily Caller | TIPPING POINT

EDITORS NOTE: This O’Keefe Media Group column is republished with permission. ©All rights reserved.